In June, Ocugen entered into an agreement with Bharat Biotech to develop, manufacture and commercialise the COVID-19 vaccine, Covaxin in Canada in addition to the existing rights in the United States.from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-|-covaxin-data-under-active-reviewcanadian-health-regulator-ocugen_15391041.html
No comments:
Post a Comment